17 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
it is important to provide protection to officers to the extent permitted by the DGCL to attract and retain executive talent. This protection has long
8-K
EX-99.2
PRME
Prime Medicine Inc
7 Aug 23
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:04pm
2021 $200M Series B 4 45 90 July 2020 July 2021 Dec 2021 July 2022 Critical Milestones Achieved Successful Growth of Talent Dec 184+ Oct 2022 ~$200M
10-Q
x51e3mrb
14 Nov 22
Quarterly report
4:46pm
424B4
wa4v63319 xmt3
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
z9yu0afx5tu49bta3
13 Oct 22
IPO registration (amended)
10:51am
S-1
l1j lcr62e
23 Sep 22
IPO registration
4:12pm
DRS/A
timii
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
0b63yfb
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
hf5 n3qiu
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
wwlgcaty
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
0d7xpnc
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
sc3rvwtrun4huo4zw
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
jjw1x
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next